The NF-κB pathway may play an important role in chemo-resistance; therefore, the discovery of novel molecules capable of regulating aberrant activation of the NF-κB pathway may facilitate the treatment of chemo-resistant cancers. This evidence concerns the gene NFKB1 and cancer.